Antibiotic stewardship in community-acquired pneumonia

References

• Lee JS, Giesler DL, Gellad WF, et al. Antibiotic therapy for adults hospitalized with community-acquired pneumonia: a systematic review. JAMA. 2016;315(6):593–602.
   PubMed Web of Science ®Google Scholar
• José RJ, Periselneris JN, Brown JS. Community-acquired pneumonia. Curr Opin Pulm Med. 2015;21(3):212–218.
   PubMed Web of Science ®Google Scholar
• Mandell LA. Community-acquired pneumonia: an overview. Postgrad Med. 2015;127(6):607–615.
   PubMed Web of Science ®Google Scholar
• Mortensen EM, Metersky ML. Long-term mortality after pneumonia. Semin Respir Crit Care Med. 2012;33(3):319–324.
   PubMed Web of Science ®Google Scholar
• Broulette J, Yu H, Pyenson B, et al. The incidence rate and economic burden of community-acquired pneumonia in a working-age population. Am Health Drug Benefits. 2013;6(8):494–503.
   PubMedGoogle Scholar
• Carratalà J, Garcia-Vidal C, Ortega L, et al. Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia: a randomized controlled trial. Arch Intern Med. 2012;172(12):922–928.
   PubMedGoogle Scholar
• McCormick D, Fine MJ, Coley CM, et al. Variation in length of hospital stay in patients with community-acquired pneumonia: are shorter stays associated with worse medical outcomes? Am J Med. 1999;107(1):5–12.
   PubMed Web of Science ®Google Scholar
• Burk M, El-Kersh K, Saad M, et al. Viral infection in community-acquired pneumonia: a systematic review and meta-analysis. Eur Respir Rev. 2016;25(140):178–188.
   PubMed Web of Science ®Google Scholar
• Viasus D, Garcia-Vidal C, Carratalà J. Advances in antibiotic therapy for community-acquired pneumonia. Curr Opin Pulm Med. 2013;19(3):209–215.
   PubMed Web of Science ®Google Scholar
• Mandell LA, Wunderink RG, Anzueto A, et al.; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44(Suppl 2):S27–S72.
   PubMed Web of Science ®Google Scholar
• Woodhead M, Blasi F, Ewig S, et al.; Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections – full version. Clin Microbiol Infect 2011;17(Suppl 6):E1–E59.
   PubMed Web of Science ®Google Scholar
• Postma DF, van Werkhoven CH, van Elden LJ, et al.; CAP-START Study Group. Antibiotic treatment strategies for community-acquired pneumonia in adults. N Engl J Med. 2015; 372(14):1312–1323.
   PubMed Web of Science ®Google Scholar
• Haubitz S, Hitz F, Graedel L, et al. Ruling out Legionella in community-acquired pneumonia. Am J Med. 2014;127(10):1010.e11-9.
   PubMed Web of Science ®Google Scholar
• Fiumefreddo R, Zaborsky R, Haeuptle J, et al. Clinical predictors for Legionella in patients presenting with community-acquired pneumonia to the emergency department. BMC Pulm Med. 2009;9:4.
   PubMedGoogle Scholar
• Fernandez-Sabe N, Roson B, Carratalà J, et al. Clinical diagnosis of Legionella pneumonia revisited: evaluation of the Community-Based Pneumonia Incidence Study Group scoring system. Clin Infect Dis. 2003;37:483–489.
   PubMed Web of Science ®Google Scholar
• Gupta SK, Imperiale TF, Sarosi GA. Evaluation of the Winthrop-University Hospital criteria to identify Legionella pneumonia. Chest. 2001;120:1064–1071.
   PubMed Web of Science ®Google Scholar
• Doron S, Davidson LE. Antimicrobial stewardship. Mayo Clin Proc. 2011;86(11):1113–1123.
   PubMed Web of Science ®Google Scholar
• Hand K. Antibiotic stewardship. Clin Med (Lond). 2013;13(5):499–503.
   PubMed Web of Science ®Google Scholar
• Barlam TF, Cosgrove SE, Abbo LM, et al. Executive summary: implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):1197–1202.
   PubMed Web of Science ®Google Scholar
• Pollack LA, van Santen KL, Weiner LM, et al. Antibiotic stewardship programs in U.S. acute care hospitals: findings from the 2014 National Healthcare Safety Network Annual Hospital Survey. Clin Infect Dis. 2016;63(4):443–449.
   PubMed Web of Science ®Google Scholar
• Dellit TH, Owens RC, McGowan JE, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159–177.
   PubMed Web of Science ®Google Scholar
• ASHP statement on the pharmacist’s role in antimicrobial stewardship and infection prevention and control. Am J Health Syst Pharm. 2010;67(7):575–577.
   PubMedGoogle Scholar
• Morgan DJ, Croft LD, Deloney V, et al. Choosing wisely in healthcare epidemiology and antimicrobial stewardship. Infect Control Hosp Epidemiol. 2016;37(7):755–760.
   PubMed Web of Science ®Google Scholar
• Davey P, Brown E, Charani E, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013;(4):CD003543.
   PubMed Web of Science ®Google Scholar
• Goldstein EJ, Goff DA, Reeve W, et al. Approaches to modifying the behavior of clinicians who are noncompliant with antimicrobial stewardship program guidelines. Clin Infect Dis. 2016;63(4):532–538.
   PubMed Web of Science ®Google Scholar
• Hurst JM, Bosso JA. Antimicrobial stewardship in the management of community-acquired pneumonia. Curr Opin Infect Dis. 2013;26(2):184–188.
   PubMed Web of Science ®Google Scholar
• Athanassa Z, Makris G, Dimopoulos G, et al. Early switch to oral treatment in patients with moderate to severe community-acquired pneumonia: a meta-analysis. Drugs. 2008;68(17):2469–2481.
   PubMed Web of Science ®Google Scholar
• Engel MF, Postma DF, Hulscher ME, et al. Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP. Eur Respir J. 2013;41(1):123–130.
   PubMed Web of Science ®Google Scholar
• Engel MF, Bruns AH, Hulscher ME, et al. A tailored implementation strategy to reduce the duration of intravenous antibiotic treatment in community-acquired pneumonia: a controlled before-and-after study. Eur J Clin Microbiol Infect Dis. 2014;33(11):1897–1908.
   PubMed Web of Science ®Google Scholar
• Mortensen EM, Restrepo M, Anzueto A, et al. Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia. Am J Med. 2004;117(10):726–731.
   PubMed Web of Science ®Google Scholar
• McCabe C, Kirchner C, Zhang H, et al. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules. Arch Intern Med. 2009;169(16):1525–1531.
   PubMedGoogle Scholar
• Frei CR, Attridge RT, Mortensen EM, et al. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit. Clin Ther. 2010;32(2):293–299.
   PubMed Web of Science ®Google Scholar
• Yamana H, Matsui H, Tagami T, et al. De-escalation versus continuation of empirical antimicrobial therapy in community-acquired pneumonia. J Infect. 2016;73(4):314–325.
   PubMed Web of Science ®Google Scholar
• Khasawneh FA, Karim A, Mahmood T, et al. Safety and feasibility of antibiotic de-escalation in bacteremic pneumonia. Infect Drug Resist. 2014;7:177–182.
   PubMed Web of Science ®Google Scholar
• Carugati M, Franzetti F, Wiemken T, et al. De-escalation therapy among bacteraemic patients with community-acquired pneumonia. Clin Microbiol Infect. 2015;21(10):936.e11-8.
   PubMed Web of Science ®Google Scholar
• Viasus D, Simonetti AF, Garcia-Vidal C, et al. Impact of antibiotic de-escalation on clinical outcomes in community-acquired pneumococcal pneumonia. J Antimicrob Chemother. 2016. doi:10.1093/jac/dkw441. [Epub ahead of print].
   PubMedGoogle Scholar
• Tabah A, Cotta MO, Garnacho-Montero J, et al.; Working Group for Antimicrobial Use in the ICU. A systematic review of the definitions, determinants, and clinical outcomes of antimicrobial de-escalation in the intensive care unit. Clin Infect Dis 2016;62(8):1009–1017.
   PubMed Web of Science ®Google Scholar
• Weiss E, Zahar JR, Lesprit P, et al.; De-escalation Study Group. Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams. Clin Microbiol Infect 2015;21(7):649.e1-10.
   Google Scholar
• Guillemot D, Carbon C, Balkau B, et al. Low dosage and long treatment duration of β-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA. 1998;279(5):365–370.
   PubMed Web of Science ®Google Scholar
• Opmeer BC, El Moussaoui R, Bossuyt PM, et al. Costs associated with shorter duration of antibiotic therapy in hospitalized patients with mild-to-moderate severe community-acquired pneumonia. J Antimicrob Chemother. 2007;60(5):1131–1136.
   PubMed Web of Science ®Google Scholar
• Li JZ, Winston LG, Moore DH, et al. Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis. Am J Med. 2007;120(9):783–790.
   PubMed Web of Science ®Google Scholar
• Dimopoulos G, Matthaiou DK, Karageorgopoulos DE, et al. Short- versus long-course antibacterial therapy for community-acquired pneumonia: a meta-analysis. Drugs. 2008;68(13):1841–1854.
   PubMed Web of Science ®Google Scholar
• Uranga A, España PP, Bilbao A, et al. Duration of antibiotic treatment in community-acquired pneumonia: a multicenter randomized clinical trial. JAMA Intern Med. 2016;176(9):1257–1265.
   PubMed Web of Science ®Google Scholar
• El Moussaoui R, de Borgie CA, van den Broek P, et al. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. BMJ. 2006;332(7554):1355.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Müller B, Christ-Crain M, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2012;(9):CD007498.
   Google Scholar
• Schuetz P, Briel M, Christ-Crain M, et al. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis. Clin Infect Dis. 2012;55(5):651–662.
   PubMed Web of Science ®Google Scholar
• McIntosh KA, Maxwell DJ, Pulver LK, et al. A quality improvement initiative to improve adherence to national guidelines for empiric management of community-acquired pneumonia in emergency departments. Int J Qual Health Care. 2011;23(2):142–150.
   PubMed Web of Science ®Google Scholar
• Høgli JU, Garcia BH, Skjold F, et al. An audit and feedback intervention study increased adherence to antibiotic prescribing guidelines at a Norwegian hospital. BMC Infect Dis. 2016;16:96.
   PubMed Web of Science ®Google Scholar
• Halpape K, Sulz L, Schuster B, et al. Audit and Feedback-Focused approach to Evidence-based Care in Treating patients with pneumonia in hospital (AFFECT study). Can J Hosp Pharm. 2014;67(1):17–27.
   PubMedGoogle Scholar
• Avdic E, Cushinotto LA, Hughes AH, et al. Impact of an antimicrobial stewardship intervention on shortening the duration of therapy for community-acquired pneumonia. Clin Infect Dis. 2012;54(11):1581–1587.
   PubMed Web of Science ®Google Scholar
• Marcos PJ, Restrepo MI, Sanjuàn P, et al. Community-acquired pneumonia team decreases length of stay in hospitalized, low-risk patients with pneumonia. Hosp Pract (1995). 2013;41(3):7–14.
   PubMedGoogle Scholar
• Marrie TJ, Lau CY, Wheeler SL, et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA. 2000;283(6):749–755.
   PubMed Web of Science ®Google Scholar
• Morris AM, Brener S, Dresser L, et al. Use of a structured panel process to define quality metrics for antimicrobial stewardship programs. Infect Control Hosp Epidemiol. 2012;33(5):500–506.
   PubMed Web of Science ®Google Scholar